ResearcherXiamen UniversityNo recent work listed

Wengang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6980-1776; OpenAlex author ID A5077957321. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway. Last author DOI 10.3892/ijo.2023.5491 ↗
Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients with local advanced stage Co-author DOI 10.21203/rs.3.rs-2118396/v1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Changsheng Zhou · 1 shared paper, 2023 · strength 0.22
- Paper Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway. DOI 10.3892/ijo.2023.5491 ↗
Jun Jia · 1 shared paper, 2022 · strength 0.19
- Paper Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients with local advanced stage DOI 10.21203/rs.3.rs-2118396/v1 ↗
Xuezhang Duan · 1 shared paper, 2022 · strength 0.19
- Paper Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients with local advanced stage DOI 10.21203/rs.3.rs-2118396/v1 ↗
Jing Sun · 1 shared paper, 2022 · strength 0.19
- Paper Stereotactic body radiation therapy as an effective treatment for pancreatic cancer patients with local advanced stage DOI 10.21203/rs.3.rs-2118396/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.